Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Jun-22 4:13 PM View:  | Genocea Biosciences, Inc. (GNCA) | 02-Jun-22 | Sale | 1,355 | $0.06 | $81.30 | (2%) 76.74K to 75.39K | |
| 26-May-22 4:11 PM View: | Genocea Biosciences, Inc. (GNCA) | 26-May-22 | Sale | 24,407 | $0.08 | $1,867.14 | (24%) 101.15K to 76.74K | |
| 05-Apr-22 8:17 AM View: | Genocea Biosciences, Inc. (GNCA) | 04-Apr-22 | Private Sale | 963 | $1.25 | $1,203.75 | (1%) 92.74K to 91.78K | |
| 17-Mar-22 4:11 PM View: | Genocea Biosciences, Inc. (GNCA) | 16-Mar-22 | Sale | 2,873 | $1.10 | $3,160.30 | (3%) 95.61K to 92.74K | |
| 17-Mar-22 4:11 PM View: | Genocea Biosciences, Inc. (GNCA) | 15-Mar-22 | Grant | 37,500 | -- | -- | 65% 58.11K to 95.61K | |
| 16-Mar-22 10:00 PM View: | Genocea Biosciences, Inc. (GNCA) | 01-Jun-21 | Market Sale | 511 | $2.23 | $1,139.53 | (< 1%) 63.0K to 62.49K | 51% |
| 16-Mar-22 10:00 PM View: | Genocea Biosciences, Inc. (GNCA) | 02-Apr-21 | Market Sale | 925 | $2.71 | $2,506.75 | (1%) 63.92K to 63.0K | 60% |
| 17-Mar-21 1:59 PM View: | Genocea Biosciences, Inc. (GNCA) | 15-Mar-21 | Grant | 37,500 | -- | -- | 100% 0 to 37.5K | |
| 02-Jun-20 4:19 PM View: | Genocea Biosciences, Inc. (GNCA) | 01-Jun-20 | Grant | 6,623 | -- | -- | 100% 0 to 6.62K | |
| 06-Apr-20 4:06 PM View: | Genocea Biosciences, Inc. (GNCA) | 02-Apr-20 | Grant | 12,299 | -- | -- | 100% 0 to 12.3K | |
| 08-Mar-18 12:22 PM View: | Bioverativ Inc. (BIVV) | 08-Mar-18 | Disposition | 2,791 | -- | -- | (100%) 2.79K to 0 | |
| 05-Mar-18 5:02 PM View: | Bioverativ Inc. (BIVV) | 02-Mar-18 | Payment of Exercise | 105 | $104.73 | $10,996.70 | (4%) 2.9K to 2.79K | (< 1%) |
| 26-Feb-18 5:13 PM View: | Bioverativ Inc. (BIVV) | 22-Feb-18 | Payment of Exercise | 168 | $104.30 | $17,522.40 | (5%) 3.06K to 2.9K | (< 1%) |
| 15-Feb-18 5:11 PM View: | Bioverativ Inc. (BIVV) | 14-Feb-18 | Payment of Exercise | 454 | $103.52 | $46,998.10 | (13%) 3.52K to 3.06K | (1%) |
| 15-Feb-18 5:11 PM View: | Bioverativ Inc. (BIVV) | 14-Feb-18 | Option Exercise | 1,390 | -- | -- | 65% 2.13K to 3.52K | |
| 29-Jun-17 5:10 PM View: | Bioverativ Inc. (BIVV) | 28-Jun-17 | Market Sale (Planned) | 818 | $60.47 | $49,464.50 | (28%) 2.95K to 2.13K | (74%) |
| 03-May-17 4:27 PM View: | Bioverativ Inc. (BIVV) | 02-May-17 | Payment of Exercise | 99 | $57.48 | $5,690.52 | (3%) 3.04K to 2.95K | (83%) |
| 03-Mar-17 4:15 PM View: | Bioverativ Inc. (BIVV) | 02-Mar-17 | Payment of Exercise | 113 | $52.81 | $5,967.53 | (4%) 3.16K to 3.04K | (99%) |
| 02-Mar-17 4:10 PM View: | Bioverativ Inc. (BIVV) | 28-Feb-17 | Grant | 3,360 | -- | -- | 37333% 9 to 3.37K | |
| 02-Mar-17 4:10 PM View: | Bioverativ Inc. (BIVV) | 28-Feb-17 | Payment of Exercise | 211 | $47.76 | $10,077.40 | (6%) 3.37K to 3.16K | (120%) |